Anti-Jak2 antibody

  • Description

  • Application Data

Description

Recognises human Jak2, a non-receptor tyrosine kinase involved in immunity, cell division, cell death and tumour formation.

See full description

Application Data

Catalogue number crb2005683
Antibody Anti-Jak2 antibody
Antigen Peptide KLH conjugated synthetic peptide crb1200892
Protein ID UniProtKB - Q62689
Aliases Tyrosine-protein kinase Jak2, Jak-2, Janus kinase 2
Cross-Reactivity Rat
Host Species Rabbit
Antibody Type Polyclonal
Concentration 0.5 mg/mL Glycine (R1G), 0.5 mg/mL Glycine (R2G), 0.1 mg/mL TEA (R2T)
Target Jak2
Family Tyr Protein Kinase family (Jak subfamily)
Super Family Protein Kinase superfamily
Storage This material is supplied in PBS containing 0.01% sodium azide and 1% trehalose. The product should be stored at +4°C for short term storage and -20°C for long term storage. Avoid repeated freeze/thaw cycles.
References

Jay et al., (2014). JAK2 Tyrosine Kinase Phosphorylates and Is Negatively Regulated by Centrosomal Protein Ninein. Mol Cell Biol35(1): 111. PMID:25332239.

Liu et al., (2017). Cbl-mediated K63-linked ubiquitination of JAK2 enhances JAK2 phosphorylation and signal transduction. Sci Rep7(1). PMID: 28676638.

Trivedi et al., (2018). Drosophila Jak/STAT Signaling: Regulation and Relevance in Human Cancer and Metastasis. Int J Mol Sci19(12): 4056. PMID: 30558204.

Data Sheet Data Sheet Data Sheet Material Safety Data Sheet (MSDS)

Janus kinase-2 (Jak2) is a non-receptor tyrosine kinase implicated in signalling via members of the type II cytokine receptor family (such as interferon receptors), the GM-CSF receptor family (IL-3R, IL-5R and GM-CSF-R), the gp130 receptor family (e.g., IL-6R), and the single chain receptors (e.g. Epo-R, Tpo-R, GH-R, PRL-R). The Jak/signal transducer and activator of transcription (STAT) pathway is a key cellular pathway involved in immunity, cell division, cell death and tumour formation. The Jak/STAT pathway is activated by leptin and the leptin receptor. It results in the phosphorylation of STAT3 and its translocation to the nucleus, where it activates the transcription of various target genes.

Mutations and gene fusions involving Jak2 have been implicated in polycythemia vera, essential thrombocythemia, myelofibrosis, other myeloproliferative disorders and leukaemia.

Anti-Jak2 antibody

Cat No.Pack SizePriceQty.
20µg£50.00
20µg£50.00
20µg£50.00
Bulk Quote

You may also like…

  • Anti-IL-11 antibody

    View products
  • IRS-1 substrate

    CKKSRGDYMTMQIG-acid

    View products
  • Anti-JAK3 antibody

    View products
  • IL-11 peptide

    View products
  • [5-FAM]-IFN-γ receptor (pTyr) peptide[5-FAM]-G-[pY]-DKPH-V-L-amide

    View products
  • [G]-JAK1 peptide (1015-1027)GAIETDKEYYTVKD-acid

    View products
  • [G]-JAK1 peptide (1015-1027) p(Y1022)GAIETDKE-[pY]-YTVKD-acid

    View products
  • JAK2 peptide

    View products
  • Anti-IL23A antibody

    View products
  • Biotin-Jak2 substrateBiotin-GGEEEEYFELVKK-acid

    View products
  • Jak2 substrateGGEEEEYFELVKK-acid

    View products
  • Anti-JAK3 antibody

    View products
  • Anti-Jak2 antibody

    View products
  • Anti-JAK3 antibody

    View products
  • Biotin phosphorylated JAK1 substrate peptideBiotin-CAGAGAIETDKEY-[pY]-TVKD-acid

    View products
  • Anti-JAK2 antibody

    View products
  • [Cys(AF647)]-Jak2/3 substrate[Cys(AF647)]-GGEEEEYFELVKK-acid

    View products